期刊文献+

孟鲁司特钠辅助治疗儿童支原体肺炎效果观察 被引量:5

下载PDF
导出
摘要 目的探讨孟鲁司特钠辅助治疗儿童支原体肺炎(MPP)效果。方法 239例MPP患儿分为观察组122例和对照组117例。两组均常规应用阿奇霉素和对症布地奈德雾化治疗,观察组加用孟鲁司特钠口服。观察治疗前,治疗1周、2周、4周及停药后3个月时患儿最大呼气流速(PEF)及临床效果。结果①治疗1周、2周、4周及停药后3个月,观察组的肺功能达标率均高于对照组,差异有统计学意义。两组肺功能达标率均随治疗时间的延长而呈上升趋势,至治疗4周时达高峰,停药3个月时肺功能达标率略有下降。②观察组在治疗后1周、2周时临床控制率均高于对照组,停药3个月时复发率低于对照组,差异有高度统计学意义。结论孟鲁司特钠联合阿奇霉素治疗MPP效果好于常规阿奇霉素治疗。
出处 《中国乡村医药》 2013年第3期22-23,共2页
  • 相关文献

参考文献4

二级参考文献33

  • 1王莉华,孙若鹏,张红静,郭敏慧,杨金芝.哮喘儿童焦虑情绪与唾液SIgA测定[J].中国儿童保健杂志,2004,12(2):127-129. 被引量:7
  • 2黄志勇,张军.高危患者术后TNF-α及IL-6水平变化与感染性并发症及MODS关系的研究[J].中华医院感染学杂志,2007,17(5):486-487. 被引量:10
  • 3ten Brinke A.Risk factors associated with irreversible airflow limitation in asthma[J].Curr Opin Allergy Clin Immunol,2008,8(1):63-69.
  • 4吴瑞萍,胡亚美,江载芳.实用儿科学[M].第6 版.北京:人民卫生出版社,1997: 1136-1182.
  • 5Min JW,Park SM,Rhim TY,Park SW,Jang AS,Uh ST,et al.Effect and mechanism of lipopolysaccharide on allergen-induced interleukin-5 and eotaxins production by whole blood cultures of atopic asthmatics[J].Clin Exp Immunol,2007,147(3):440-448.
  • 6Doherty T,Broide D.Cytokines and growth factors in airway remodeling in asthma [J].Curr Opin Immunol,2007,19(6):676-680.
  • 7Hubeau C,Apostolou I,Kobzik L.Adoptively transferred allergen-specific T cells cause maternal transmission of asthma risk[J].Am J Pathol,2006,168(6):1931-1939.
  • 8El Bassam S,Pinsonneault S,Kornfeld H,Ren F,Menezes J,Laberge S.Interleukin-16 inhibitsinterleukin-13 production by allergen-stimulated blood mononuclearcells[J].Immunology,2006,117 (1):89-96.
  • 9Kabesch M,Schedel M,Carr D.IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma[J].J Allergy Clin Immunol,2006,117(2):269-274.
  • 10Abraham JH,Finn PW,Milton DK,Ryan LM,Perkins DL,Gold DR.Infant home endotoxin is associated with reduced allergen-stimulated lymphocyte proliferation and IL-13 production in childhood.[J].J Allergy Clin Immunol,2005,116(2):431-437.

共引文献115

同被引文献50

  • 1管频,于化鹏,李伟,吴智勇,吴洁,陈世良.慢性阻塞性肺疾病患者肺组织中核转录因子-κB、转化生长因子-β1表达与气道重塑的关系[J].中国老年学杂志,2015,35(2):313-314. 被引量:13
  • 2赖克方.咳嗽严重度界定与咳嗽激发试验[J].中国实用内科杂志,2006,26(1):15-17. 被引量:95
  • 3胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 4Vervloet LA, Marguet C, Camargos PA. Infection hy Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias [J]. Braz J Infect Dis, 2007, 11 (5) : 507-514.
  • 5Yi-Bo Wang,Alan B. Watts,Jay I. Peters,Robert O. Williams.The impact of pulmonary diseases on the fate of inhaled medicines—A review[J].International Journal of Pharmaceutics (-).2014(1-2)
  • 6Min Hyok Jeon,Jin-Won Chung,Seong-Ho Choi,Tae Hyong Kim,Eun Jung Lee,Eun Ju Choo.Pneumonia risk factors and clinical features of hospitalized patients older than 15 years with pandemic influenza A (H1N1) in South Korea: a multicenter study[J].Diagnostic Microbiology & Infectious Disease.2011(2)
  • 7Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma[J]. Respiration, 2011, 83 (4) . 308-315.
  • 8Tajiri T, Niimi A, Matsumoto H, et al. Prevalence and clinical relevance of allergic rhinitis in patients with classic asthma and cough variant asthma[J]. Respiration,2014,87(3) :211-218.
  • 9Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and anti-inflammatory effect o montelukast in patients with cough variant asthma [J]. Respiration,2012,83 (4) :308-315.
  • 10Yang YC,Zhang N, van Crombruggen K, et al. Transforming growth factor-beta 1 in inflammatory airway disease: a key for understanding inflammation and remodeling [J]. Allergy, 2012,67(10) :1193-1202.

引证文献5

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部